Literature DB >> 30468463

MiR-485-5p inhibits metastasis and proliferation of osteosarcoma by targeting CX3CL1.

F-R Wang1, S-H Xu, B-M Wang, F Wang.   

Abstract

OBJECTIVE: To investigate the potential effect of miR-485-5p on the development of osteosarcoma (OA) and its relevant mechanism. PATIENTS AND METHODS: The expression level of miR-485-5p was detected in OA tissues and cells (MG-63) comparing with corresponding adjacent normal tissues and normal human osteoblastic cell lines (Hfob1.19), respectively. Luciferase assay was performed to evaluate the interaction between miR-485-5p and CX3CL1, the effects of miR-485-5p on MG-63 cells were determined by subsequent experiments including cell proliferation, expression level of CX3CL1, detection of invasion and migration capacities.
RESULTS: In our present research, miR-485-5p was down-regulated in OA tissues and we got the same result in OA cells. In order to obtain potential target of miR-485-5p, we checked it in three publicly available algorithms, TargetScan, miRDB and microRNA. We found that CX3CL1 is a direct target of miR-485-5p, and Luciferase assays confirmed our hypothesis. The results showed that decreased expression of CX3CL1 resulting from the up-regulation of miR-485-5p could decelerate cell proliferation, invasion and migration in OA cells.
CONCLUSIONS: We showed the suppressor function of miR-485-5p in OA by targeting CX3CL1, indicating that miR-485-5p/CX3CL1 axis might be a potential therapeutic target for the treatment of OA.

Entities:  

Year:  2018        PMID: 30468463     DOI: 10.26355/eurrev_201811_16253

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  11 in total

Review 1.  Chemokine Receptor Antagonists: Role in Oncology.

Authors:  Sean Kraus; Thomas Kolman; Austin Yeung; Dustin Deming
Journal:  Curr Oncol Rep       Date:  2021-09-04       Impact factor: 5.075

2.  MiR-200c-3p and miR-485-5p overexpression elevates cisplatin sensitivity and suppresses the malignant phenotypes of non-small cell lung cancer cells through targeting RRM2.

Authors:  Ying Liu; Yong Zhang; Qiubo Li; Ruiqi Xu; Nian Huang
Journal:  Thorac Cancer       Date:  2022-05-22       Impact factor: 3.223

3.  LncRNA PICSAR binds to miR-485-5p and activates TGF-β1/Smad to promote abnormal proliferation of hypertrophic scar fibroblasts (HSFs) and excessive deposition of extracellular matrix (ECM).

Authors:  Sijia Xu; Wenxin Dong; Yu Shi
Journal:  Med Mol Morphol       Date:  2021-07-13       Impact factor: 2.309

4.  Long non‑coding RNA NR2F1‑AS1 facilitates the osteosarcoma cell malignant phenotype via the miR‑485‑5p/miR‑218‑5p/BIRC5 axis.

Authors:  Guanghui Jia; Yalei Wang; Yali Yu; Zijun Li; Xiangyu Wang
Journal:  Oncol Rep       Date:  2020-07-20       Impact factor: 3.906

5.  LncRNA LINC00460 promotes the papillary thyroid cancer progression by regulating the LINC00460/miR-485-5p/Raf1 axis.

Authors:  Guangjun Li; Qingli Kong
Journal:  Biol Res       Date:  2019-12-23       Impact factor: 5.612

6.  MiR-485-3p modulates neural stem cell differentiation and proliferation via regulating TRIP6 expression.

Authors:  Juxian Gu; Rusheng Shao; Meng Li; Qiuyue Yan; Hongwei Hu
Journal:  J Cell Mol Med       Date:  2019-11-15       Impact factor: 5.310

7.  MicroRNA‑485‑5p suppresses the progression of esophageal squamous cell carcinoma by targeting flotillin‑1 and inhibits the epithelial‑mesenchymal transition.

Authors:  Riyang Zhao; Yanan Shan; Xinliang Zhou; Cong Zhang; Ruinian Zhao; Lianmei Zhao; Baoen Shan
Journal:  Oncol Rep       Date:  2021-04-13       Impact factor: 3.906

8.  RHPN1‑AS1 promotes ovarian carcinogenesis by sponging miR‑485‑5p and releasing TPX2 mRNA.

Authors:  Shoubin Cui; Cui Li
Journal:  Oncol Rep       Date:  2021-04-28       Impact factor: 3.906

9.  Silencing of long non-coding RNA NEAT1 improves Treg/Th17 imbalance in preeclampsia via the miR-485-5p/AIM2 axis.

Authors:  Jiying Chen; Yonggang Zhang; Wenqing Tan; Hanchao Gao; Shuixiu Xiao; Jinhua Gao; Zhiying Zhu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

10.  Downregulation of circular RNA circ-HN1 suppressed the progression of gastric cancer through the miR-485-5p/GSK3A pathway.

Authors:  Mingming Zhang; Yingheng Jiang
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.